Genetic defects in sperm from a sperm bank cannot form the basis for a products liability suit, a federal appeals court has ruled, because allowing such a claim would be tantamount to recognizing a claim of “wrongful life.”

The ruling by the 3rd U.S. Circuit Court of Appeals in Donovan v. Idant Laboratories upholds a June 2009 decision by U.S. District Judge Thomas N. O’Neill Jr. that rejected claims by both a mother and a daughter who suffers from Fragile X syndrome, a mutation known to cause a group of maladies that include mental retardation and behavioral disorders.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]